Advancing Peripheral Nerve Regeneration (Nerve SPACE 2025)

Area of Science:

• Neuroscience
• Regenerative Medicine
• Biotechnology

Background:

• Peripheral nerve injuries present significant clinical challenges.
• Slow axonal regeneration and rapid Wallerian degeneration impede functional recovery.
• Degeneration of target organs before reinnervation further complicates outcomes.

Purpose of the Study:

• To review current strategies for enhancing peripheral nerve regeneration.
• To identify key challenges hindering clinical translation of these strategies.
• To propose a framework for future research and development.

Main Methods:

• Review of existing literature on peripheral nerve injury and regeneration.
• Categorization of therapeutic approaches: delaying Wallerian degeneration, accelerating axonal regrowth, and optimizing the microenvironment.
• Analysis of barriers to clinical translation, including outcome measures and collaboration.

Main Results:

• Strategies to delay Wallerian degeneration include polyethylene glycol-mediated axonal fusion and inhibition of specific WD-executioner molecules.
• Methods to accelerate axon regrowth involve electrical stimulation and pharmacologic agents like 4-aminopyridine.
• Enhancing the microenvironment shows promise through cellular therapies (stem cells, Schwann cells, exosomes) and drug delivery.

Conclusions:

• Progress in peripheral nerve regeneration is hampered by inconsistent outcome measures and lack of standardized protocols.
• Multicenter collaboration and standardized methodologies are crucial for clinical translation.
• Integrating complementary approaches and improving mechanistic understanding are essential for achieving meaningful functional recovery.